Resultado da Busca
21 de fev. de 2021 · Brain metastases (BM) from colorectal cancer (CRC) are rare. There is little available information regarding incidence, risk factors, prognostic factors, treatment, and overall survival (OS). In this systematic review we performed a research of the current literature and exposed an average incidence of 2.10%.
10 de out. de 2022 · To investigate the clinical characteristics, survival, prognostic factors, and treatment of brain metastasis (BM) from colorectal cancer (CRC). Twenty-one patients with BM from CRC were retrospectively reviewed. Predictive factors for BM and prognostic factors after the diagnosis of BM were examined by univariate and multivariate COX ...
1 de dez. de 2012 · Article PDF Available Literature Review. Brain Metastasis of Colorectal Cancer: Microenvironment and Molecular Mechanism. December 2012. International Journal of Molecular...
22 de jan. de 2021 · Background: Colorectal cancer patients with brain metastases experience poor outcomes; however treatment strategies are understudied. In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metastases.
Brain metastasis (BM) in colorectal cancer patients is rare and is associated with dismal outcomes. Our study aims to evaluate the incidence and predictors of BM in patients with colorectal cancer. Methods. We performed a retrospective analysis (2010–2017) of patients with a primary diagnosis of colorectal cancer (CRC).
4 de fev. de 2020 · 204. Background: More than 50% of colorectal cancer (CRC) patients will develop metastatic disease. Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population.
7 de out. de 2022 · Article PDF Available. Brain metastasis from colorectal cancer: Treatment, survival, and prognosis. October 2022. Medicine 101 (40):e30273. DOI: 10.1097/MD.0000000000030273. License....
